Robert R. Conley

12.3k total citations · 2 hit papers
170 papers, 9.3k citations indexed

About

Robert R. Conley is a scholar working on Psychiatry and Mental health, Cellular and Molecular Neuroscience and Molecular Biology. According to data from OpenAlex, Robert R. Conley has authored 170 papers receiving a total of 9.3k indexed citations (citations by other indexed papers that have themselves been cited), including 106 papers in Psychiatry and Mental health, 38 papers in Cellular and Molecular Neuroscience and 29 papers in Molecular Biology. Recurrent topics in Robert R. Conley's work include Schizophrenia research and treatment (96 papers), Bipolar Disorder and Treatment (39 papers) and Neuroscience and Neuropharmacology Research (23 papers). Robert R. Conley is often cited by papers focused on Schizophrenia research and treatment (96 papers), Bipolar Disorder and Treatment (39 papers) and Neuroscience and Neuropharmacology Research (23 papers). Robert R. Conley collaborates with scholars based in United States, United Kingdom and Italy. Robert R. Conley's co-authors include Deanna L. Kelly, Rosalinda C. Roberts, Yogesh Dwivedi, Hooriyah S. Rizavi, Carol A. Tamminga, Ghanshyam N. Pandey, Robert W. Buchanan, Ramy Mahmoud, William T. Carpenter and Raymond C. Love and has published in prestigious journals such as New England Journal of Medicine, Journal of Biological Chemistry and Journal of Neuroscience.

In The Last Decade

Robert R. Conley

170 papers receiving 8.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Altered Gene Expression of Brain-Derived Neurotrophic Factor and Receptor Tyrosine Kinase B in Postmortem Brain of Suicide Subjects

2003 667 citations Yogesh Dwivedi, Hooriyah S. Rizavi et al. Archives of General Psychiatry profile →
Evaluation of Galcanezumab for the Prevention of Episodic Migraine

2018 408 citations Virginia L. Stauffer, David W. Dodick et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Robert R. Conley United States	52	4.8k	2.3k	1.7k	1.4k	1.3k	170	9.3k
David Copolov Australia	51	3.8k 0.8×	2.3k 1.0×	1.7k 1.0×	1.0k 0.7×	1.5k 1.1×	242	9.3k
Richard Jed Wyatt United States	51	4.3k 0.9×	3.1k 1.4×	1.3k 0.8×	1.4k 1.0×	1.2k 0.9×	193	11.0k
Daniël P. van Kammen United States	51	3.6k 0.7×	2.1k 0.9×	1.4k 0.8×	1.0k 0.8×	1.3k 1.0×	218	7.6k
P.F. Buckley United States	52	5.8k 1.2×	1.2k 0.5×	1.2k 0.7×	1.9k 1.4×	2.7k 2.0×	332	10.5k
Janusz Rybakowski Poland	53	5.9k 1.2×	1.3k 0.6×	1.2k 0.7×	1.6k 1.2×	2.6k 1.9×	466	11.3k
Michael Riedel Germany	52	3.5k 0.7×	928 0.4×	1.8k 1.1×	1.3k 0.9×	2.5k 1.8×	219	9.7k
Wagner F. Gattaz Brazil	64	6.1k 1.3×	2.1k 0.9×	2.5k 1.5×	1.6k 1.2×	1.9k 1.4×	387	14.5k
Michael Davidson United States	52	6.6k 1.4×	1.7k 0.7×	1.4k 0.8×	2.1k 1.5×	931 0.7×	195	10.7k
Herbert Y. Meltzer United States	40	3.2k 0.7×	1.8k 0.8×	1.1k 0.7×	819 0.6×	1.2k 0.9×	60	5.9k
H. Beckmann Germany	44	2.6k 0.5×	2.6k 1.1×	1.6k 0.9×	813 0.6×	920 0.7×	254	7.9k

Countries citing papers authored by Robert R. Conley

Since Specialization

Citations

This map shows the geographic impact of Robert R. Conley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert R. Conley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert R. Conley more than expected).

Fields of papers citing papers by Robert R. Conley

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert R. Conley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert R. Conley. The network helps show where Robert R. Conley may publish in the future.

Co-authorship network of co-authors of Robert R. Conley

This figure shows the co-authorship network connecting the top 25 collaborators of Robert R. Conley. A scholar is included among the top collaborators of Robert R. Conley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert R. Conley. Robert R. Conley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bardos, Jennifer, Peter J. Goadsby, David W. Dodick, et al.. (2019). A Placebo-Controlled Study of Galcanezumab in Patients with Episodic Cluster Headache: Results from the 8-Week Double-Blind Treatment Phase (Plen02.004). Neurology. 92(15_supplement). 2 indexed citations

Ascher‐Svanum, Haya, et al.. (2012). Cost-effectiveness of several atypical antipsychotics in orally disintegrating tablets compared with standard oral tablets in the treatment of schizophrenia in the United States. Journal of Medical Economics. 15(3). 531–547. 30 indexed citations

Ascher‐Svanum, Haya, Xiaomei Peng, D Faries, Robert R. Conley, & Kory Schuh. (2011). Decline in hospitalization risk and health care cost after initiation of depot antipsychotics in the treatment of schizophrenia. SHILAP Revista de lepidopterología. 3. 9–9. 49 indexed citations

Boggs, Douglas L., Deanna L. Kelly, Robert P. McMahon, et al.. (2011). Rimonabant for neurocognition in schizophrenia: A 16-week double blind randomized placebo controlled trial. Schizophrenia Research. 134(2-3). 207–210. 34 indexed citations

Stauffer, Virginia L., Bruce J. Kinon, Haya Ascher‐Svanum, et al.. (2011). Responses to antipsychotic therapy among patients with schizophrenia or schizoaffective disorder and either predominant or prominent negative symptoms. Schizophrenia Research. 134(2-3). 195–201. 34 indexed citations

Stauffer, Virginia L., Michael Case, Bruce J. Kinon, et al.. (2010). Early response to antipsychotic therapy as a clinical marker of subsequent response in the treatment of patients with first-episode psychosis. Psychiatry Research. 187(1-2). 42–48. 52 indexed citations

Kelly, Deanna L., et al.. (2009). Nonresponse to clozapine and premorbid functioning in treatment refractory schizophrenia. Comprehensive Psychiatry. 51(3). 298–302. 10 indexed citations

Kelly, Deanna L., Robert P. McMahon, Elaine Weiner, et al.. (2008). Lack of beneficial galantamine effect for smoking behavior: A double-blind randomized trial in people with schizophrenia. Schizophrenia Research. 103(1-3). 161–168. 28 indexed citations

Kelly, Deanna L., Robert R. Conley, Stephanie Feldman, et al.. (2006). Adjunct Divalproex or Lithium to Clozapine in Treatment-Resistant Schizophrenia. Psychiatric Quarterly. 77(1). 81–95. 55 indexed citations

10.

Dwivedi, Yogesh, Amal Chandra Mondal, Hooriyah S. Rizavi, et al.. (2006). Differential and Brain Region–Specific Regulation of Rap-1 and Epac in Depressed Suicide Victims. Archives of General Psychiatry. 63(6). 639–639. 43 indexed citations

11.

Dwivedi, Yogesh, Amal Chandra Mondal, Hooriyah S. Rizavi, & Robert R. Conley. (2005). Suicide Brain Is Associated with Decreased Expression of Neurotrophins. Biological Psychiatry. 58(4). 315–324. 94 indexed citations

12.

Dwivedi, Yogesh, Jagadeesh S. Rao, Hooriyah S. Rizavi, et al.. (2003). Abnormal Expression and Functional Characteristics of Cyclic Adenosine Monophosphate Response Element Binding Protein in Postmortem Brain of Suicide Subjects. Archives of General Psychiatry. 60(3). 273–273. 144 indexed citations

13.

Sakai, Kazuo, et al.. (2000). Ionotropic Glutamate Receptors and Expression of N-Methyl-d-Aspartate Receptor Subunits in Subregions of Human Hippocampus: Effects of Schizophrenia. American Journal of Psychiatry. 157(7). 1141–1149. 297 indexed citations

14.

Carpenter, William T. & Robert R. Conley. (1999). Sense and nonsense:. Schizophrenia Research. 35(3). 219–225. 120 indexed citations

15.

Conley, Robert R., Raymond C. Love, Deanna L. Kelly, & John J. Bartko. (1999). Rehospitalization Rates of Patients Recently Discharged on a Regimen of Risperidone or Clozapine. American Journal of Psychiatry. 156(6). 863–868. 79 indexed citations

16.

Kelly, Deanna L., Robert R. Conley, & C.A. Tamminga. (1999). Differential olanzapine plasma concentrations by sex in a fixed-dose study. Schizophrenia Research. 40(2). 101–104. 64 indexed citations

17.

Lahti, Robert A., et al.. (1996). D2-type dopamine receptors in postmortem human brain sections from normal and schizophrenic subjects. Neuroreport. 7(12). 1945–1948. 31 indexed citations

18.

Dixon, Lisa B., Gunvant K. Thaker, Robert R. Conley, et al.. (1993). Changes in psychopathology and dyskinesia after neuroleptic withdrawal in a double-blind design. Schizophrenia Research. 10(3). 267–271. 31 indexed citations

19.

Holcomb, Henry H., Nicola G. Cascella, Deborah R. Medoff, et al.. (1993). PET-FDG Test-Retest Reliability During a Visual Discrimination Task in Schizophrenia. Journal of Computer Assisted Tomography. 17(5). 704–709. 20 indexed citations

20.

Conley, Robert R. & Robert W. Baker. (1990). Family Response to Improvement by a Relative With Schizophrenia. Psychiatric Services. 41(8). 898–901. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact